Poly(ADP-ribose) polymerases (PARPs) catalyze the poly(ADP-ribosyl)ation of proteins. This posttranslational modification, as generated by the DNA d a mage-activated enzymes PARP-1 and -2, has long been known to be involved in DNA repair. Correlative data have suggested an association between DNA damage-induced poly(ADP-ribosyl)ation and mammalian longevity, and this link has recently been strengthened by the discovery of interactions between PARP-1 and the Werner syndrome protein.
Introduction
Aging is the time-dependent general decline in phy s i o l og i c a l function of an organism, which is accompanied by a progr e s s ively increased risk of morbidity and mortality (1) . At the cellular ment that can be masked by functional redundancy. Furt h e rmore, both PARP-1 (9) and PARP-3 (10) are detected at centrioles and centrosomes, which to some extent seem to be regulated by poly(ADP-ribosyl)ation (discussed below).
PARP-1 is one of the first proteins to be cleaved in the execution phase of apoptosis (11) . This cleavage may fulfill several functions. First, it may be that cleavage of PARP-1 by apoptotic proteases (caspase 3 or 7) inhibits DNA repair either by abrogating DNA damage signaling through separating the catalytic C -t e rminus of PARP-1 from its DNA binding domain (DBD), or by blocking the access of other DNA repair enzymes to DNA strand breaks introduced by endonucleases in the course of apoptosis (as the PARP-1 DBD sticks to DNA ends), or both. Second, excessive PARP-1 activity consumes a substantial amount of energ y, and so PARP-1 inactivation would conserve energy needed for the completion of apoptosis. Telomeres are another important cellular structure that can be influenced by poly(ADP-ribosyl)ation. Ta n kyrases (TNKS-1 and TNKS-2, also term e d PARP-5) as well as PARP-1 and PARP-2 are invo l ved in telomere maintenance (1 2- 1 6) . Ta n kyrases have also been shown to take part in vesicle trafficking by interaction with IRAP [ins u l i n -r e s p o n s ive amino peptidase (1 7) ], a protein resident in endocytic vesicles also bearing the glucose transporter GLUT4, which upon insulin stimulation is inserted into the plasma membrane. Fi n a l ly, another poly(ADP-ribose) poly m e r a s e that has been inve s t i gated in some detail is PA R P -4, the so-called vault PARP (1 8) . Vault part i c l e s are large cytoplasmic multicomponent stru c t u r e s , and although their function in normal cells is unclear at present, they may be invo l ved in mult i d rug resistance of cancer cells. As is ev i d e n t from human genome sequence searches, there appear to be a number of additional PARP isoform s awaiting elucidation of their functional releva n c e .
PARPs in DNA Repair
As noted above, both PARP-1 and PARP-2 are activated by DNA strand breaks. During the process of base excision repair ( h t t p : / / s a g e ke . s c i e n c e m a g . o rg / c g i / c o n t e n t / f u l l / 2 0 0 3 / 8 / r e 3 # S E C 2 ) , these two enzymes are thought to regulate the accessibility of n i c ked DNA to other repair enzymes.
In base excision repair, modified bases are first recognized by specific DNA glycosylases; they are then excised and the abasic DNA strand is cut. After this, one of two subpathways is employed: short-patch (SP) or long-patch (LP) base excision rep a i r. During the main SP repair pathway, DNA polymerase β
Human PARP-1 has a three-domain structure. Numbers indicate the amino acids bordering distinct domains. FI and FII are the two zinc fingers present in PARP-1, with C denoting cysteine and H histidine. NLS denotes the bipartite nuclear localization signal.
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Schematic view of the biosynthesis of poly(ADP-ri b o s e ) . N A D + i s cleaved into nicotinamide (NAM, orange) and an ADP-ribosyl (blue) residue by PARP (magenta), and the ADP-ribose moieties are attached to an acceptor protein (green).
( Pol β) removes the abasic deoxyribose-phosphate moiety and inserts a single nucleotide. DNA ligase III then reseals the interrupted strand. Both Pol β and ligase III bind to the scaffold protein XRCC1, which also binds PARP-1 and PARP-2. During LP base excision repair, DNA polymerases ε, δ, or β synthesize a s h o rt stretch of new DNA, thus displacing the old damaged strand. Flap endonuclease 1 (FEN1) cleaves the resulting overhang, and the DNA is resealed by DNA ligase I (19) .
It is believed that PARP-1 (and perhaps PARP-2) attracts other repair proteins to the side of damage, via poly ( A D P -r ibose) formation, and orchestrates the decision about wh i c h route of repair to choose. PARP-1 and PARP-2 knockout mice both show severe defects in DNA repair, as well as an increased s e n s i t ivity to challenge with ionizing radiation or alky l a t i n g agents. A recent paper postulates that the poly ( A D Pribosyl)ation system is always engaged but is not essential for the execution of the base excision repair process in vitro, suggesting that it is not the PARPs themselves but their poly(ADPribosyl)ated products that are required for effective DNA repair (2 0). A plausible mechanism for the contribution of the poly(ADP-ribosyl)ation system that was suggested many years ago (21) and has recently gained strong support (22, 23) is that it brings about local chromatin relaxation, either by cova l e n t m o d i fication of histones or by noncovalent interaction of histones with a poly ( A D P -r i b o s e ) -m o d i fied PA R P. A l t e rn a t ive ly, p o ly(ADP-ribose) may be required to orchestrate other eve n t s i nvo l ved in DNA repair, such as regulation of the cell cy c l e , DNA replication (http://sageke.sciencemag.org/cgi/content/full/ sageke;2003/8/re3), or transcription machineries. Indeed, it has been shown that tumor suppressor protein p53 (http://sageke . s c i e n c e m a g . o rg / c g i / g e n e d a t a / s a g e keGdbGene;212), the "guardian of the genome," is not only a substrate for direct modification by poly(ADP-ribose) but can bind to the polymer in a noncovalent fashion (24) (25) (26) (27) (28) . In PARP-1-depleted cells, the concentration of the DNA-polymerase α/primase protein comp l ex (http://sageke . s c i e n c e m a g . o rg / c g i / c o n t e n t / f u l l / 2 0 0 3 / 8 / re3#SEC3) is reduced and DNA replication is affected (27, 28) . A d d i t i o n a l ly, transcription of some genes is disturbed in the absence of PARP-1, and it is notewo rt hy that the enzyme has been l i n ked to the general transcription machinery, facilitating accurate transcription initiation [PARP-1 has been isolated independently as an RNA polymerase II transcription fa c t o r, TFII-C (2 9)].
PARP-1 has also been shown to interact with DNA -d e p e ndent protein kinase (DNA-PK), the initial activator of the nonhomologous end-joining DNA repair pathway (30) . DNA-PK is a heterotrimeric protein kinase consisting of two regulatory subunits, Ku70 and Ku80, and a catalytic subunit, DNA-PKcs. It belongs to the family of DNA damage-activated phosphatidylinositol 3-kinase-like protein kinases, which also comprises the proteins ATM (ataxia telangiectasia mutated) and ATR (AT M related). DNA-PK binds to and is activated by doubl e -s t r a n d DNA breaks and interacts with several other proteins, including p53 (3 1), PARP-1 (3 0), and WRN [the product of the We rn e r syndrome gene; see below (3 2) ]. DNA-PK is important for D NA repair by the nonhomologous end-joining pathway and f o rmation of the B and T cell repertoire, as well as telomere capping. Loss of DNA-PK function by a spontaneous mouse mutation led to the development of severe combined immunode fi c i e n cy syndrome [for a rev i ew, see (3 3) ]. PARP-1 is phosp h o rylated by DNA-PK and in turn can modify the cataly t i c subunit of DNA-PK.
The cellular functions of poly(ADP-ribosyl)ation under conditions of genotoxic stress have been inve s t i gated by inhibiting PARP activity through treatment of cells or organisms with lowm o l e c u l a r-weight compounds (mainly NA D + a n a l ogs), by expression of PA R P -1 antisense RNA or of dominant nega t ive d e r iva t ives of PARP-1, or by genetic means. For example, expression of the PARP-1 DBD gr e a t ly sensitizes cells to DNA damage induced by γ i rradiation or alkylating agents (3 4) . T h e DBD behaves as a dominant nega t ive mutant, competing with wild-type PARP for DNA strand breaks and thus inhibiting DNA damage-dependent poly(ADP-ribosyl)ation. As a consequence, cells undergo apoptosis more readily, and the rate of mutations (3 5) and gene amplification (3 6) is increased in surv iving cells. C o nve r s e ly, ove r expression of full-length PARP-1 (3 7) leads to a greater abundance of poly(ADP-ribose) in cells and less genomic instability after challenge with genotoxic agents.
Such studies have established that, in proliferating cells exposed to low levels of genotoxic stress, poly(ADP-ribosyl)ation contributes to recovery from cytotoxicity. Genomic instability is s u p p r e s s e d, as assessed by measurement of several biolog i c a l markers such as chromosomal aberrations, gene amplification, SCEs, or mutagenesis, establishing PARP-1 and PARP-2 as cyt o p r o t e c t ive factors. Increased concentrations of poly ( A D P -r ibose) lead to greater genomic stability, whereas inhibiting the p o ly(ADP-ribosyl)ation system renders cells more susceptibl e to the effects of DNA damage such as induction of mutations, gene amplifications, or apoptosis. Last but not least, seve r e damage to DNA can trigger "overshooting" by PARP-1, leading to excessive NAD + consumption, adenosine triphosphate depletion, and subsequent cell death owing to energy depletion (38) . This phenomenon can be achieved by either acute ove r a c t ivation or sustained activity of PARP, coupled with inadequate regeneration capacity for NA D + . This suicidal ove r a c t ivation of PARP has been reported in several nonproliferative cell types in vivo as well as in cell culture, including (i) pancreatic islet cells undergoing destruction in type I diabetes induced by ROS, nitric oxide (NO), or its metabolites, or by the drug streptozotocin; (ii) neurons destroyed after ischemia-reperfusion damage, where ex c e s s ive production of ROS and NO also takes place; (iii) the death of dopaminergic neurons in the MPTP (1-methyl-4 -p h e ny l -1 , 2 , 3 , 6 -t e t r a hy d r o pyridine, a drug inducing ROS formation specifi c a l ly in this type of neuron)-induced model of Pa r k i n s o n 's disease (http://sageke . s c i e n c e m a g . o rg / cgi/content/full/2001/7/dn4); (iv) cell death in the postischemic heart; and (v) the death of endothelial cells, leading to vascular dysfunction. On the one hand, impaired PARP activity leads to less eff e c t ive repair of DNA damage, and on the other hand PARP ove r a c t ivity leads to cell destruction. Either extreme may lead to cell and tissue malfunction, one of the hallmarks of aging.
Poly(ADP-Ribosyl)ation and Mammalian Life Span
S everal years ago, we described a correlation betwe e n p o ly(ADP-ribosyl) formation and the life span of mammalian species, comparing the maximally achievable PARP activity in p e rmeabilized blood mononuclear cells (MNCs) of 13 mammalian species (39) . We found a strong positive correlation between the polymer synthesis capacity per cell and the longevity of a species, with the difference between the shortest-(rat) and the longest-lived species (human) being fivefold. This diff e rence was not due to different PARP-1 protein concentrations, as measured by We s t e rn blotting, which suggests that the diff e r-ences in activity were a result of subtle variations in primary s t ructure, the overall protein sequence homology between rat and human PARP-1 being about 94% (40) . When rat and human PARP-1 were expressed in the baculovirus system, analysis of the enzymic automodification reaction revealed that human PARP-1 displayed a poly(ADP-ribosyl)ation capacity that wa s twice that of the rat enzyme (41) . Although these data demonstrated that there is indeed a primary structure-dependent difference in PARP-1 activity as a function of species, this could not fully account for the difference seen in our comparative analyses of MNCs. It may be that accessory proteins modulate PARP activity after DNA damage within the cell.
We also showed that ly m p h o blastoid cell lines establ i s h e d using peripheral blood samples from French centenarians s h owed a signifi c a n t ly higher poly(ADP-ribosyl)ation capacity than control cell lines (4 2), as measured by specific enzyme a c t ivity (cellular PARP-1 activity divided by the amount of cellular PARP-1 protein). In a DNA sequencing approach, we i d e n t i fied four new poly m o rphisms in the human PA R P -1 c o ding region, but none of them was associated with human l o n g evity in our sample (4 3). This result again suggests that hypothetical accessory factors are important for the reg u l a t i o n of PARP-1 activ i t y.
PARPs and Cellular Processes Involved in Aging
As noted above, PARPs are also implicated in the aging process through an invo l vement in various cellular systems other than DNA repair.
PARPs and telomere s
Telomeres play an important role in defining the "life span" of human cells in culture (3 6) (and see Horn s by Pe r s p e c t ive at h t t p : / / s a g e ke . s c i e n c e m a g . o rg / c g i / c o n t e n t / f u l l / 2 0 0 3 / 3 0 / p e 2 1 ) . Normal somatic cells isolated from the human body, such as fibroblasts, are able to undergo only a limited number of cell divisions (dependent on the age of the donor) before they reach the so-called "Hayflick limit," cease dividing, and become senescent, exhibiting phenotypic changes such as cellular flattening and expression of a senescence-associated βga l a c t o s idase. Such cells are arrested in the G 1 phase of the cell cycle, distinct from quiescent cells arrested in G 0 . After acquiring the senescent phenotype, cells are still viable and can be maintained in culture for several months (see "More Than a Sum of Our Cells" at http://sageke . s c i e n c e m a g . o rg / c g i / c o n t e n t / f u l l / sageke;2001/1/oa4).
The telomeres of primary cells shorten with each div i s i o n owing to the "end-replication problem" (4 4), because conve ntional DNA polymerases need a free 3′ hy d r oxyl group for DNA synthesis. This is usually provided by the activity of the DNA polymerase α/primase complex, which synthesizes an initial RNA oligonucleotide primer. During lagging strand synthesis on linear duplex DNA, the most distally located primer is not replaced, leading to a loss of at least 25 bases from telomeres for each round of DNA replication. Endogenous oxidative DNA damage makes an additional contribution to telomere erosion in replicating fibroblasts, and this can be strongly accelerated by DNA damage induced by ROS or alkylating agents from exogenous sources [for a review, see (45) ], further linking D NA damage to the aging process. Telomeric DNA in mammals comprises repeats of TTAGGG hexanucleotides, ending in a 3′ single-strand overhang. The telomere is covered by dimers of the telomeric repeat binding factors TRF-1 and TRF-2, and TRF-2 is responsible for the putative t-loop structure adopted by telomere ends (46, 47) . The termini of telomeres are folded back, and the free single strand invades the adjacent doubl estranded region of DNA, thus building a ternary DNA complex. This unusual arrangement probably shields the telomere from recognition by the DNA double-strand break repair machinery.
In germline cells and tissue stem cells, including their highly p r o l i f e r a t ive prog e ny, the multicomponent enzyme telomerase counteracts telomeric sequence loss (48) . It is thought that the telomeric t-loop structure has to be unfolded before telomerase can access the telomere and elongation can take place. This is achieved by inhibiting binding of TRF-1 and/or TRF-2. At least four members of the PARP family-TNKS-1, TNKS-2, PARP-1, and PARP-2-are localized to telomeric DNA and are able to modify TRF-1 and TRF-2 respective ly, thus inhibiting their D NA binding activity (1 4, 4 9) . In T N K S -1 -ove r ex p r e s s i n g cells, for example, this leads to an increase in telomere length. Because the PARP activity of tankyrases inhibits the binding of TRF-1 to the telomere, telomerase activity is facilitated, and the cell can avoid senescence caused by telomere erosion. Very rec e n t ly, Dynek and Smith used a small interfering RNA ( h t t p : / / s a g e ke . s c i e n c e m a g . o rg / c g i / c o n t e n t / f u l l / 2 0 0 3 / 3 0 / n w 1 0 5 ) -based approach to reduce TNKS-1 activity, which led to mitotic arrest of cells by blocked segregation of telomeres (16) .
The involvement of PARP-1 and PARP-2 connects DNA repair to telomere length regulation. PARP-1 has been found to coimmunoprecipitate with TRF-2 in HeLa cell extracts and has been shown to modify it in vitro (1 5). PARP-2 interacts with TRF-2 in ALT (alternative lengthening of telomeres) cells within nuclear structures referred to as PML (pro-mye l o cy t i c l e u kemia) bodies, and modifies and inhibits TRF-2 in vitro (ALT cells use a telomerase-independent mechanism of telomere lengthening, probably involving DNA recombination events taking place in PML bodies). In this context, PARP-2 knockout mice display a higher frequency of unprotected telomeres and increased chromosomal instability (14) .
PARP and WRN protein
There are several rare genetic disorders that induce premature aging in humans, one being Werner syndrome (WS), which is caused by a mutation in the W R N gene (http://sageke . s c ie n c e m a g . o rg / c g i / g e n e d a t a / s a g e keGdbGene; 189) (4 2) (and see "Of Hyperaging and Methuselah Genes" at http://sageke . s c ie n c e m a g . o rg / c g i / c o n t e n t / f u l l / s a g e ke;2001/1/ns2). The W R N protein (http://sageke . s c i e n c e m a g . o rg / c g i / c o n t e n t / f u l l / 2 0 0 4 / 13/re3) is a member of the RecQ helicase family, possessing an additional exonuclease activ i t y, and forms part of the DNA replication complex, cooperating with several DNA replicationand repair-related proteins (3 2, 5 0- 5 5) . Recently, it has been s h own that PA R P -1 and WRN cooperate functionally in preventing carcinogenesis in vivo, because mice lacking both PARP-1 and WRN genes exhibit an increased frequency of chromosomal aberrations and earlier onset of tumor formation as compared to WRN-mutated mice (50) . In WS cells, poly(ADPribosyl)ation after DNA damage by hy d r ogen peroxide and methyl methane sulfonate (single-strand DNA break inducers), but not by bl e o mycin (a double-strand break inducer), is impaired, pointing to a loss of repair capacity dependent on the repair pathway involved (56) . There is also a link to telomeres and DNA repair, as WRN interacts with TRF-2 (57, 58) and FEN-1, as well as with the Ku70 subunit of DNA-PK (3 2), the same protein complex with which PARP-1 associates (30, 32) .
PARP and mitosis E rrors in mitotic chromosomal segr egation are one pathway leading to aneuploidy and represent a step toward tumor formation. Inaccurate chromosome segregation can result if multipolar rather than bipolar mitotic spindles are formed. For proper bipolar spindle formation, the centrosomes, which organize the poles of the spindle in most animal cells, must duplicate once and only once per cell division cycle. In this context, it is notewo rt hy that PARP-1, PARP-3, and probably TNKS-1 as we l l (59) are involved in regulating centrosomes and centrioles (mic r o t u bule-based structures that form part of the centrosome). PARP-3 is localized at the daughter centriole and interacts with PARP-1 at this location (10) . PARP-1 itself has been shown to modify centrosomal proteins, and inhibition of its activity leads to hy p e r a m p l i fication of centrosomes, giving rise to aberr a n t cell division (9) . Furt h e rmore, PARP-1 binds to and modifi e s s everal centromere-organizing proteins such as Bub3, CenpA, and CenpB (60) .
PARP and inflammation
Ultraviolet damage is important in the aging of skin, inducing signaling through many cytokine receptors [for a rev i ew, see (61) ]. Nuclear factor kappa B (NF-κB), a master transcription factor in cytokine signaling, is tightly coupled with inflammatory responses [for a rev i ew, see (6 2) ]. As revealed by ex p e r iments on PA R P -1 k n o c kout mice, NF-κB is dependent on the presence of PARP-1 protein, which is probably acting as an acc e s s o ry transcriptional coactivator (6 3-6 5) . In the absence of PARP-1, NF-κB fails to induce the inflammatory cascade, thus rendering PARP-1 knockout animals resistant to septic shock and a variety of other pathophysiological conditions (66) (67) (68) (69) (70) . In this context, PARP-1 is important for regulation of the immune response but might also be viewed as a "pro-aging" factor because it is complicit in tissue damage involving inflammation.
Concluding Remarks
PARP proteins are crucial players in the cellular responses to various kinds of insult to genomic DNA, be it oxidative DNA damage, telomere erosion, or improper segregation of chromosomes. PARPs appear to provide cells and organisms with very versatile tools to fight various kinds of threat to genomic int egr i t y, thus keeping in check aging-related malfunctions such as cancer formation and cell loss, and consequently may contribute to "healthy aging."
In this review, we have brought together some quite disparate lines of evidence supporting an involvement of members of the PARP family in the aging process ( Fig. 3) . First, because genotoxic stress (mainly induced by ROS) is believed to be the major driving force of cellular aging, mechanisms that counteract it or reverse its consequences are important for genetic integrity.
A key pathway for eliminating oxidative DNA damage, spontan e o u s ly formed abasic sites, or DNA single-strand breaks is DNA base excision repair, and the activity of this repair pathway seems to be facilitated by PARP-1 and PARP-2. Indeed, the capacity of blood MNCs to synthesize poly(ADP-ribose) shows a positive correlation with the life span of mammalian donor species. Second, the maintenance of telomere length is very imp o rtant in allowing replicating human cells to avoid cellular senescence and replicative crisis. Two PARPs, TNKS-1 and -2, serve as regulators of telomere length, modifying TRF-1 and alleviating its negative influence on telomerase activity; PARP-1 and PARP-2 can modify TRF-2 and thus "open up" the telomeric t-loop structure. T h i r d, PARPs can interact with gene products such as the WRN protein that serve to prevent premature aging and retard age-related diseases. Fo u rth, because seve r a l PARPs are components of the mitotic apparatus and appear to have a regulatory function governing chromosome segregation, t h ey may also counteract genomic instability indirectly. Fi f t h , by interacting with important cell cycle regulators such as p53, PARPs [and like ly their reaction product poly ( A D P -r i b o s e ) ] take an active part in DNA damage surveillance and the regulation of cell division (Fig. 4 ). Fi n a l ly, inflammatory processes are induced by or themselves mediate the formation of ROS. Inflammation is strictly reliant on the activity of the NF-κB transcription factor system, and this depends on the role of PARP-1 protein as a transcriptional coactivator.
PARPs are clearly versatile agents, participating in many cellular regulatory tasks. They have been reported to be present in eve ry cellular compartment, including mitochondria (7 1), although the latter localization is subject to debate. Poly(ADP-ribose) polymers translocate from the nucleus after genotox i c stress, and it has been shown that the polymer is the main if not the only trigger for the release of apoptosis-inducing fa c t o r from mitochondria [for a rev i ew, see (7 2) ]. One function of PARG is the degradation of polymer to counteract this signal for apoptosis.
Although poly(ADP-ribose) polymers and PARP-1 have been known since 1964, their essential functions have not ye t been fully elucidated. The emergence of even more PARPs with partially overlapping functions makes the situation more comp l ex, but it also broadens the spectrum of possible ways for cells to use the basal function that all PARPs have in common, n a m e ly poly(ADP-ribosyl)ation. in mind that all ADP-ribose polymers may not be created equal: S h o rt and long, unbranched and highly branched poly m e r s might well have different effects on cell signaling, repair, and survival. Although this year brings the 40th anniversary of the discovery of poly(ADP-ribosyl)ation, the chapter is unlikely to be closed soon. 
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